The immunosuppressive drugs used for the treatment of psoriasis may affect the clinical presentation and outcome of COVID 19 infection. Herein, we report a 73 year old male patient with severe psoriasis being treated with cyclosporine CsA 100mg daily plus methotrexate MTX 7.5 mg weekly biologic treatment was not accessible who experienced disease flare up after the discontinuation of psoriasis treatment during COVID 19 infection....